Canton Hathaway’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$729K Sell
2022
Q1
$695K Buy
2021
Q4
$780K Buy
2021
Q3
$625K Hold
2021
Q2
$437K Hold
2021
Q1
$308K Sell
2020
Q4
$417K Buy
2020
Q3
$293K Buy
2020
Q2
$197K Buy
2020
Q1
Sell
2019
Q4
$163K Buy
2019
Q3
$83K Buy